Efforts to develop PREPL inhibitors were already made by other researchers [44]; consequently, the observations published here can motivate the usage of these obtained compounds to this end, including the possibility that the association of POP and PREPL inhibitors may improve the beneficial effects on PD treatment tests observed so far with POP inhibitors alone [26,31,36,38]. This evidence concerns the gene PREPL and Parkinson disease.